Shares of Inovio Pharmaceuticals fell sharply after the biotech company priced a public stock and warrant offering at $0.95 per unit, aiming to raise $20 million in a move that dilutes existing shareholders.
Oracle stock gained 3.3% after the company announced it will integrate Google's Gemini artificial intelligence models into its suite of enterprise applications, including Fusion and NetSuite.
Pharmaceutical giant Eli Lilly and contract manufacturer Resilience are committing $750 million to expand a facility in Ohio, aiming to boost production of key medicines like the KwikPen injectable device and create 400 new jobs.
A broad selloff led by Meta Platforms is hitting the AI sector as investors scrutinize massive capital expenditures and rising credit risks at companies like NVIDIA and Oracle, questioning the tangible returns on AI infrastructure.
The mining giant's stock climbed after it posted a 28% rise in first-half underlying EBITDA and a 43% increase in its interim dividend, leading to a series of analyst upgrades.
HSBC has lowered its rating on Procter & Gamble to 'Hold' from 'Buy' and cut its price target, citing concerns that the company's reinvestment strategy has yet to deliver a sustained recovery in sales volumes or margins.
The consumer health giant reported first-half organic revenue growth of 2.6%, raising doubts about its ability to meet its 4-6% annual target despite exceeding profit expectations.
Mizuho raised its rating on Bloom Energy to 'Outperform' from 'Neutral,' pointing to better-than-expected execution and an attractive entry point after a recent stock pullback, despite trimming its price target.
Atoms, the industrial AI venture from Uber co-founder Travis Kalanick, has raised $1.7 billion in a funding round that includes rival Uber, signaling a potential long-term shift in food delivery logistics that could challenge DoorDash's gig-economy model.
